Nova Chemicals executive Mark Kay passes away

Canadian Plastics group

首页> 外文期刊>Canadian Plastics >Nova Chemicals executive Mark Kay passes away

【24h】

Nova Chemicals executive Mark Kay passes away

机译：Nova Chemicals Executive Mark Kay通过

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Mark Kay, an executive with Calgary-based Nova Chemicals Corp., passed away on Oct. 19 while attending the K 2019 trade show in Dusseldorf, Germany. Kay, 56, died suddenly of a heart attack, according to an obituary notice. Kay was Nova's performance films group leader, and worked from the company's office in Moon Township, Pa., near Pittsburgh.

机译：Mark Kay是一名高级行政，总部位于卡尔加里的Nova Chemicals Corp.，于10月19日通过，同时参加德国杜塞尔多夫的K 2019展览展。凯斯，56，突然死亡，心脏病发作，根据ob告通知。凯是新星的表演电影集团领导，并从公司办公室在帕茨堡旁边的月球镇。

著录项

来源
《Canadian Plastics》 |2019年第5期|共1页
作者
Canadian Plastics group;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类合成树脂与塑料工业;
关键词

相似文献

外文文献
中文文献
专利

1. Nova Chemicals executive Mark Kay passes away [J] . Canadian Plastics group Canadian Plastics . 2019,第5期

机译：Nova Chemicals Executive Mark Kay通过
2. Ian M. Kay, Longtime Director of the Cast Metals Institute, Passes Torch to Successor [J] . Modern Casting . 2006,第8期

机译：铸造金属研究所的长期主任Ian M. Kay将火炬传递给继任者
3. Nova, TransCanada Agree to Merge; Nova Chemicals Will Stand Alone [J] . Petro Chemical News group PetroChemical News . 1998,第5期

机译：TransCanada的Nova公司同意合并; Nova Chemicals将独自站立
4. VDBA Tabanl? Kay?ps?z ve Kay?pl? Endüktans Benzetimleri ve Filtre Uygulamalar? [C] . Abdullah Yesil, Firat Kacar IEEE Signal Processing and Communications Applications Conference . 2016

机译：VDBA为基础？凯？ps？z和kay？pl？电感介质和过滤器应用程序？
5. PAST TIMES IN FRENCH: A STUDY OF THE PASSE SIMPLE-PASSE COMPOSE DISTRIBUTION, WITH REFERENCE TO SPANISH AND ITALIAN [D] . BRILL, JANA ALENA 1983

机译：过去的法国时间：通过西班牙文和意大利文的通行简单通行证组成分布研究
6. CMA Online passes the million mark [O] . 2000

机译：CMA Online突破百万大关
7. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology31This document was approved by the American College of Cardiology Board of Trustees in August 2001, the American Heart Association Science Advisory and Coordinating Committee in August 2001, and the European Society of Cardiology Board and Committee for Practice Guidelines and Policy Conferences in August 2001.32When citing this document, the American College of Cardiology, the American Heart Association, and the European Society of Cardiology would appreciate the following citation format: Fuster V, Rydén LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, Kay GN, Klein WW, Lévy S, McNamara RL, Prystowsky EN, Wann LS, Wyse DG. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol 2001;38:1231–65).33This document is available on the World Wide Web sites of the American College of Cardiology (http://www.acc.org), the American Heart Association (http://www.americanheart.org), the European Society of Cardiology (http://www.escardio.org), and the North American Society of Pacing and Electrophysiology (http://www.naspe.org). Single reprints of this document (the Executive Summary and Summary of Recommendations) is available by calling 800-253-4636 (US only) or writing the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 20814-1699. To obtain a reprint of the complete guidelines published in the mid-October issue of the European Heart Journal, call +44 207 424 4200 or +44 207 424 4389, fax +44 207 424 4433, or write Harcourt Publishers Ltd, European Heart Journal, ESC Guidelines - Reprints, 32 Jamestown Road, London, NW1 7BY, United Kingdom. To purchase additional reprints, specify version and reprint number (Executive Summary 71-0208; Full-Text 71-0209): up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 214-706-1466, fax 214-691-6342; or E-mail pubauth@heart.org. [O] . Fuster Valentin, Rydén Lars E, Asinger Richard W, 2001

机译：ACC / AHA / ESC治疗房颤患者的指南：执行摘要美国心脏病学会/美国心脏协会实践指南工作组和欧洲心脏病学会实践指南委员会和政策会议的报告与北美起搏和电生理学会合作制定的《房颤患者治疗管理指南》 31该文件于2001年8月获得美国心脏病学会理事会的批准，于8月获得美国心脏协会科学咨询与协调委员会的批准2001年，以及2001年8月召开的欧洲心脏病学会理事会和实践指南与政策委员会会议。32引用该文件时，美国心脏病学会，美国心脏协会和欧洲心脏病学会将赞赏以下引用格式：Fuster V，RydénLE， Asinger RW，Cannom DS，Crijns HJ，Frye RL，Halperin JL，Kay GN，Klein WW，LévyS，McNamara RL，Prystowsky EN，Wann LS，Wyse DG。 ACC / AHA / ESC治疗房颤患者的指南：执行摘要：美国心脏病学会/美国心脏协会实践指南工作组和欧洲心脏病学会实践指南委员会和政策会议的报告（委员会制定房颤患者治疗指南）。 J Am Coll Cardiol 2001; 38：1231-65）.33本文档可在美国心脏病学会（http://www.acc.org），美国心脏协会（http://www.acc.org）的万维网站点上找到。 www.americanheart.org），欧洲心脏病学会（http://www.escardio.org）和北美起搏和电生理学会（http://www.naspe.org）。可致电800-253-4636（仅适用于美国）或写信给美国心脏病，教育服务学院，地址为9111 Old Georgetown Road，Bethesda，MD 20814-1699，获得本文档的单版（执行摘要和建议摘要）。要获得《欧洲心脏杂志》十月中发行的完整指南的重印本，请致电+44 207 424 4200或+44 207 424 4389，传真+44 207 424 4433，或写信给《欧洲心脏杂志》 Harcourt Publishers Ltd ，ESC指南-转载，英国伦敦詹姆斯敦路32号，NW1 7BY。要购买其他重印本，请指定版本和重印编号（执行摘要71-0208；全文71-0209）：最多999份，请致电800-611-6083（仅限美国）或传真413-665-2671；或1000或更多副本，请致电214-706-1466，传真214-691-6342;或发送电子邮件至pubauth@heart.org。

Nova Chemicals executive Mark Kay passes away

摘要

著录项

相似文献

相关主题

期刊订阅